Press release
Sickle Cell Disease Drug Development: Industry Size, Trends, Market Outlines, Assesses the Key Opportunities & Forecasts, 2017
Market Research Report
This report provides an overview of the Sickle Cell Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for sickle cell anemia and vaso-occlusive crisis associated with sickle cell disease, and features dormant and discontinued projects.
Sickle cell anemia is a genetic (inherited) blood disorder in which red blood cells, which carry oxygen around the body, develop abnormally. Signs and symptoms include anemia, delayed growth, vision problems, pain and frequent infections. There are a total of 62 products in development for this indication, by 45 companies and nine academic institutions. Hemoglobin and a range of histone deacetylases are the most common molecular targets being studied in sickle cell anemia.
Vaso-occlusive crisis associated with sickle cell disease is a painful episode that occurs in people who have sickle cell anemia. Symptoms include fever, pain, fatigue, abdominal pain and swelling, headaches, shortness of breath, dehydration and infection. There are a total of 10 products in development for this indication.
To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1394151
Scope
- Which companies are the most active within each pipeline?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in this disease area?
Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration
Browse TOC @ https://www.researchmoz.us/sickle-cell-disease-drug-development-pipeline-review-2017-report.html/toc
1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Sickle Cell Disease Report Coverage 7
2.2 Sickle Cell Disease Overview 7
2.3 Vaso-Occlusive Crisis Associated With Sickle Cell Disease Overview 7
3 Therapeutics Development 8
3.1 Sickle Cell Disease 8
3.2 Vaso-Occlusive Crisis Associated With Sickle Cell Disease 15
4 Therapeutics Assessment 18
4.1 Sickle Cell Disease 18
4.2 Vaso-Occlusive Crisis Associated With Sickle Cell Disease 25
5 Companies Involved in Therapeutics Development 31
5.1 Sickle Cell Disease 31
5.2 Vaso-Occlusive Crisis Associated With Sickle Cell Disease 47
6 Dormant Projects 52
6.1 Sickle Cell Disease 52
6.2 Vaso-Occlusive Crisis Associated With Sickle Cell Disease 54
7 Discontinued Products 55
7.1 Vaso-Occlusive Crisis Associated With Sickle Cell Disease 55
8 Product Development Milestones 56
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sickle Cell Disease Drug Development: Industry Size, Trends, Market Outlines, Assesses the Key Opportunities & Forecasts, 2017 here
News-ID: 851716 • Views: …
More Releases from Sickle Cell Disease Drug Development
Sickle Cell Disease Drug Development Pipeline Review Thriving Worldwide with Acc …
Researchmoz added Most up-to-date research on "Sickle Cell Disease Drug Development Pipeline Review Thriving Worldwide with Acceleron Pharma Inc, Bioverativ Inc, Daiichi Sankyo Co Ltd, Genethon SA and Novartis AG" to its huge collection of research reports.
This report provides an overview of the Sickle Cell Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for sickle cell anemia and…
More Releases for Crisis
Hypertensive Crisis Agents Market - Empowering Emergency Response: Hypertensive …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Hypertensive Crisis Agents Market.
Hypertensive Crisis Agents Market: https://www.growthplusreports.com/report/hypertensive-crisis-agents-market/9142
The Hypertensive Crisis Agents Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the…
Building Safety Crisis Risks Banking Crisis
The Grenfell fire in 2017 exposed a catastrophic failure in fire safety regulation that has left tens of thousands of people living in unsafe buildings. Leaseholders-through no fault of their own-were facing facing bills running into the tens, or even hundreds, of thousands of pounds for the remediation of fire safety defects. The Building Safety Act 2022 provides leaseholders with varying degrees of statutory protection from the costs of cladding…
Digitalizing Crisis
It has been half a year since the global action on the COVID pandemic began. The lockdown, isolation and related terms are now a part of everyone’s life. Inevitably, this changed the industry of marketing, especially considering the online behavior.
As expected, there is a direct relationship between the strength of restrictions and the GDP value. Less trivial (but still not surprising) is the fact that the web search volume corresponding…
Talking Ukraine Crisis, Eurasia and U.S.A. - Michel Montecrossa's Song shows way …
’Talking Ukraine Crisis, Eurasia and U.S.A.’, is Michel Montecrossa’s New-Topical-Song, released by Mira Sound Germany on Audio Single and DVD showing the solution for leading out of the crisis. The video ’Talking Ukraine Crisis, Eurasia and U.S.A.’ is available on the Michel Montecrossa Homepage and the Single can be downloaded from Bandcamp.
Michel Montecrossa says:
“The New-Topical-Song ‘Talking Ukraine Crisis, Eurasia and U.S.A.’ shows the solution for leading out of the crisis:
The…
Brazilian Investment Beats Crisis
Obelisk International News, Marbella, Spain, October 24 2011. With most of Europe in financial and economic straits, Brazil beckons as the place for investment opportunities. The country is well set to weather the global crisis and may even benefit from it, a huge plus for Brazilian investments.
Based on Moody’s latest comments on the Brazilian economy, the Financial Times (FT) blog beyondbrics claims Brazil is the best place to beat the…
The Financial Crisis in Greece
Dominating the headlines, the financial crisis in Greece has resulted in split opinions and the effects it will have in Britain and across Europe.
There are now worries about Italy, as their banks stocks were suspended on Friday following a steep drop in their share prices. There are also concerns that Italian banks face possible ratings downgrades.
The Duetsche Bank said: “The recent weakness has put Italy's structural problem in focus. This…
